Ocean Biomedical, Inc. SEC filings OCEA
Ocean Biomedical, Inc. has 255 filings in SEC EDGAR's recent list, going back to Jul 19, 2021. Its latest annual report, Form 10-K, was filed on Apr 8, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 15, 2025, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Aug 5, 2025 (listing notice, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice, Officer or director change, Other events
|
Aug 5, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Agreement ended
|
Jul 16, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Agreement ended
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Listing notice, Officer or director change, Other events
|
Apr 23, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 1, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Other events
|
Mar 26, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 20, 2025 | Mar 14, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Feb 26, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 21, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Feb 12, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 15, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Auditor change
|
Dec 17, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Listing notice
|
Dec 11, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Listing notice
|
Dec 9, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Auditor change
|
Dec 6, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Nov 22, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 29, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 22, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 17, 2024 | Oct 11, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 23, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 23, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
May 30, 2024 | May 22, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Apr 24, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Listing notice
|
Jan 19, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Listing notice
|
Jan 17, 2024 | Jan 11, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Nov 30, 2023 | Nov 22, 2023 |
| 8-K |
Current report
Restatement
|
Nov 15, 2023 | Nov 10, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Oct 12, 2023 | Oct 6, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 6, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 3, 2023 | Oct 2, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 6, 2023 | Aug 30, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 8, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Material agreement
|
May 26, 2023 | May 25, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights
|
May 16, 2023 | May 15, 2023 |
| 8-K/A | Amended current report | Mar 31, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 27, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Material agreement
|
Feb 17, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 15, 2023 | Feb 14, 2023 |
| 8-K/A |
Amended current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
|
Feb 15, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
|
Feb 15, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Material agreement
|
Feb 13, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Material agreement
|
Feb 13, 2023 | Feb 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 13, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Material agreement
|
Feb 10, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 9, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 8, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Feb 7, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 6, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 1, 2023 | Feb 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 30, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 24, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2023 | Jan 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2022 | Dec 15, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 13, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 8, 2022 | Dec 5, 2022 |
| 8-K |
Current report
Material agreement
|
Nov 21, 2022 | Nov 17, 2022 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Nov 4, 2022 | Nov 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 1, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 1, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Material agreement
|
Oct 5, 2022 | Oct 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 22, 2022 | Sep 22, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 19, 2022 | Sep 18, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 12, 2022 | Sep 12, 2022 |
| 8-K |
Current report
Material agreement
|
Sep 9, 2022 | Sep 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 8, 2022 | Sep 8, 2022 |
| 8-K |
Current report
Material agreement
|
Sep 8, 2022 | Aug 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 6, 2022 | Sep 6, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 31, 2022 | Aug 31, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jul 19, 2022 | Jul 18, 2022 |
| 8-K |
Current report
Material agreement
|
Jul 8, 2022 | Jul 8, 2022 |
| 8-K |
Current report
Material agreement
|
Jun 2, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2022 | May 26, 2022 |
| 8-K |
Current report
Other events
|
Nov 3, 2021 | Nov 3, 2021 |
| 8-K |
Current report
Other events
|
Sep 23, 2021 | Sep 17, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Sep 17, 2021 | Sep 13, 2021 |
Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCEA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1869974
- Former names
- Ocean Biomedical, Inc./DE (until Feb 15, 2023); Aesther Healthcare Acquisition Corp. (until Feb 14, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.